A Novel Incremental Step Test as an Alternative for the Assessment of Exercise Capacity in Patients With COPD
1 other identifier
observational
50
1 country
1
Brief Summary
According to the official guidelines of pulmonary rehabilitation, a structured home-based approach is recommended to answer to the inadequate number of pulmonary rehabilitation services due to the chronic obstructive pulmonary disease (COPD) patient's needs. For this new setting, new strategies for the assessment of exercise capacity and exercise training are essential. The modality of step can be a promising tool because it is inexpensive, portable, and reflects one of the main activities of daily living (stair climbing). The development of a new field test implies the study of the measurement properties, to facilitate the selection of tests and the interpretation of the results in rehabilitation. This project hypothesizes that the step test can be valid, reliable, and feasible to apply in this new setting of pulmonary rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2021
CompletedStudy Start
First participant enrolled
January 4, 2021
CompletedFirst Posted
Study publicly available on registry
January 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMay 9, 2023
May 1, 2023
7 months
January 3, 2021
May 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of steps
The primary outcome will be the amount of the number of steps performed in the step test
Through test completion, duration of the test 15 minutes
Distance walked
The primary outcome will be the distance walked performed in the 6-minute walk test
Through test completion, duration of the test 6 minutes
Distance walked
The primary outcome will be the distance walked performed in the incremental shuttle walk test
Through test completion, duration of the test 12 minutes
Secondary Outcomes (4)
Dyspnea during the tests
Through test completion, duration of the tests 6 and 15 minutes
Fatigue during the tests
Through test completion, duration of the tests 6 and 15 minutes
Heart rate during the tests
Through test completion, duration of the tests 6 and 15 minutes
Oxygen saturation during the tests
Through test completion, duration of the tests 6 and 15 minutes
Study Arms (1)
COPD patients
Interventions
The development of the step test will be designed according to the characteristics of other validated field tests - the walking tests (6-minute walk test and the incremental shuttle walking test) The step test will be performed on a 20 cm tall, single-step device with no handles. The criteria for stopping the test will be the same as described in standard operating procedures for the walking field tests, with the addition of the inability to follow the work rate for a period of 10 seconds. The main outcome of the test will be the highest number of steps and work rate achieved.
Eligibility Criteria
Patients attending a pneumology consultation at the hospital will be asked for permission to be contacted about the study. Those who agree will be seen by the principal investigator who will explain the nature of the study and assess eligibility for the study.
You may qualify if:
- Patients are eligible with a diagnose of chronic obstructive pulmonary disease (COPD).
You may not qualify if:
- Patients will be excluded if they have a significant cardiac, immune, musculoskeletal or neurological impairment, or any other that does not allow them to perform the tests.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Polytechnic Institute of Portolead
- Nippon Gases Portugalcollaborator
Study Sites (1)
Rui Vilarinho
Porto, 4200-072, Portugal
Related Publications (2)
Goncalves T, Carlos Winck J, Silva F, Caneiras C, Montes AM, Vilarinho R. Measurement properties of the incremental step test for people with chronic obstructive pulmonary disease: a cross-sectional study. BMJ Open. 2024 Feb 7;14(2):e078425. doi: 10.1136/bmjopen-2023-078425.
PMID: 38326260DERIVEDVilarinho R, Serra L, Aguas A, Alves C, Silva PM, Caneiras C, Montes AM. Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease. BMJ Open Respir Res. 2022 Apr;9(1):e001158. doi: 10.1136/bmjresp-2021-001158.
PMID: 35387847DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 3, 2021
First Posted
January 20, 2021
Study Start
January 4, 2021
Primary Completion
July 30, 2021
Study Completion
December 31, 2023
Last Updated
May 9, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share